Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

August 7, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Enzyme activity studied under new lens!

How does the rice blast fungus invade its host cells?

First interchangeable biosimilar insulin for diabetic patients

Enzyme activity studied under new lens!
  • BiotechToday
  • World

Enzyme activity studied under new lens!

bioxone August 2, 2021August 1, 2021

Shenade Annie Kerketta, Amity University Kolkata

The knowledge that we have about how an enzyme works is through studying its ACTIVE SITE. New technology has been developed that gives us information about an enzyme by studying beyond the active site. The new technology is called HIGH THROUGHPUT MICROFLUIDIC ENZYME KINETICS (HT-MEK). This technology combines two processes which this article will describe.

What are enzymes?

Enzymes are biomolecules that alter the rate of reaction occurring inside an organism. They are, termed BIOCATALYSTS because they speed up the reaction inside a living organism. Without them, no metabolic activity would take place because the reactions would slow down considerably. They act as fuel for the body. Majority of them are made up of amino acids.

The mechanism behind enzyme activity:

ENZYME + SUBSTRATE → ENZYME-SUBSTRATE COMPLEX → ENZYME PRODUCT COMPLEX→ DESIRED PRODUCT + FREE ENZYME.

Here, the substrate depicts the substance on which the enzyme is acting. An enzyme has a specific structure that is essential for its working. An enzyme’s function depends upon its structure. If the structure changes, so do the function. The sequence of amino acids determines an enzyme’s structure. The site of an enzyme that binds to the substrate is called BINDING SITE. The site, which carries out the catalytic function is called CATALYTIC SITE. The binding site and catalytic site together form the ACTIVE SITE.

The active site is where the substrate binds. It contains residues that hold onto the substrate until the reaction is over. The active site brings about changes in the substrate, which leads to the formation of the product. To date, only the active site, has been explored. But, is it only the active site contributing to the enzyme activity?

The new technology – HT-MEK:

 HT-MEK is the successful result of the many trials conducted, to study parts of an enzyme beyond the active site. Two concepts are behind this new development.

  1. Microfluidics: large spaces are reduced to small ones to carry out fluidic experiments. It is similar to the mechanism of integrated circuits.
  2. Cell-free protein synthesis: here, only the parts needed to generate a protein are extracted and put together into a soupy extract. This soupy extract put into small wells formed (adjacent to each other) through microfluidics will be used to generate an ENZYME.

By combining, the two technologies, many variants of the same enzyme can be generated and studied side by side. Its function is analyzed by producing mutations in it. HT-MEK also helps to analyze regions other than the active site, whether other parts contribute to the enzymatic activity.

HT-MEK was implemented on PafA, an enzyme that is well studied. Researchers did find evidence to support that there are regions beyond the active site which contribute to catalysis. They also found that many of the applied mutations resulted in misfolds. The misfolds lead to an alternate structure, which hampered catalytic function, proving that structure is crucial to enzyme activity.

Conclusion:

There are many advantages of HT-MEK. Further studies, must be initiated and, must be accepted widely. HT-MEK could provide us with a whole new set of information concerning an enzyme’s mechanism. It could help with ALLOSTERIC TARGETING, a technique to increase drug specificity. It can be used to reverse engineer enzymes to generate new enzymes. Like, we could produce enzymes that could degrade plastics using HT-MEK. This new development could change our understanding of an enzyme so, further studies must be encouraged.

Also read: Extreme heat increases tree mortality in the sub-alpine forest

References: Markin, C. J., et al. “Revealing Enzyme Functional Architecture via High-Throughput Microfluidic Enzyme Kinetics.” Science, vol. 373, no. 6553, July 2021. science.sciencemag.org, doi:10.1126/science.abf8761. https://science.sciencemag.org/content/373/6553/eabf8761

  • Why Do We Age? The Biology Of Ageing Explained
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged active site binding site cell free protein synthesis Enzyme High throughput microfluidic enzyme kinetics microfluidics misfolds

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

First interchangeable biosimilar insulin for diabetic patients

bioxone August 2, 2021

Komal Bavaskar, Mumbai university Diabetes affects around 422 million people globally, with the majority residing in low- and middle-income countries, and diabetes is directly responsible for 1.6 million mortality per year. Diabetes has already been diagnosed in over 30 million people in India. What is diabetes? It is a metabolic disorder that results in elevated […]

First interchangeable

Related Post

  • BiotechToday
  • World

Multiple Antibody Panel to treat Esophageal Squamous Cell Carcinoma (ESCC)

bioxone October 21, 2020October 21, 2020

Chitra Roy, University of Calcutta Cancer Immunotherapy work by helping the immune system to function in an efficient manner to fight cancer cells. For the immune system to start its response, it must first be able to identify and differentiate between self-part of your own body and non-self-foreign/antigen. Cancer Immunotherapy is generally divided in two […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • World

Green Tea and Coffee- The Elixir of Life?

bioxone February 21, 2021February 20, 2021

Anannya Roy, Amity University Kolkata Besides being the most common beverages drank all over the world, Green tea and Coffee have lots of other health benefits. Throughout history, their benefits have been studied on cardiovascular diseases and cancer. A recent article, published in the Journal under American Stroke Association, called Stroke, talked about how regular […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Significance of Multimodal Imaging in Diagnosis of HJMD

BioTech Today July 25, 2021July 24, 2021

Agrima Bhatt, Rajasthan University What is HJMD? HJMD or Hypotrichosis with macular dystrophy is an autosomal syndrome commonly found in young children. It is caused by a mutation in a gene CDH3, responsible for encoding a protein in hair follicles, and the retinal pigment epithelium (RPE). CDH3 encodes a glycoprotein known as P-cadherin, found at […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy